Lanzhou University Second Hospital, Department of Cardiology, 82 Cuiying Men, Lanzhou, 730030, PR China.
Lanzhou University Second Hospital, Department of Cardiology, 82 Cuiying Men, Lanzhou, 730030, PR China.
Biomed Pharmacother. 2021 Feb;134:111158. doi: 10.1016/j.biopha.2020.111158. Epub 2020 Dec 24.
Long non-coding RNAs (lncRNAs) are RNA molecules with a transcript length of more than 200 nt and lack a protein-coding ability. They regulate gene expression by interacting with protein, RNA, and DNA. Their function is closely related to their subcellular localization. In the nucleus, lncRNAs regulate gene expression at the epigenetic and transcriptional levels, and in the cytoplasm, they regulate gene expression at the post-transcriptional and translational levels. Abnormalities in lncRNAs have been confirmed to exhibit tumor suppressor or carcinogenic effects and play an important role in the development of tumors. In particular, the lung cancer-related transcript 1 (LUCAT1) located in the antisense strand of the q14.3 region of chromosome 5 was first discovered in smoking-related lung cancer. Increasing evidence have showed that LUCAT1 is involved in breast cancer, ovarian cancer, thyroid cancer, renal cell carcinoma. It is highly expressed in liver cancer and other malignant tumors and has been confirmed to be induce various malignant tumors. It regulates tumor proliferation, invasion, and migration via various mechanisms and is related to the clinicopathological characteristics of tumor patients. Thus, LUCAT1 is a potential prognostic biological marker and therapeutic target for cancer. This article reviews its expression, function, and molecular mechanism in various malignant tumors.
长链非编码 RNA(lncRNA)是一类转录本长度大于 200nt、不具有蛋白编码能力的 RNA 分子。它们通过与蛋白质、RNA 和 DNA 相互作用来调节基因表达。其功能与其亚细胞定位密切相关。在核内,lncRNA 可在表观遗传和转录水平上调节基因表达,在细胞质中,它们可在转录后和翻译水平上调节基因表达。lncRNA 异常已被证实具有肿瘤抑制或致癌作用,并在肿瘤的发生发展中发挥重要作用。特别是位于 5 号染色体 q14.3 区域反义链上的肺癌相关转录本 1(LUCAT1),最初在与吸烟有关的肺癌中被发现。越来越多的证据表明,LUCAT1 参与乳腺癌、卵巢癌、甲状腺癌、肾细胞癌等多种恶性肿瘤的发生,被证实可诱导多种恶性肿瘤的发生。它通过多种机制调节肿瘤的增殖、侵袭和迁移,并与肿瘤患者的临床病理特征有关。因此,LUCAT1 是癌症潜在的预后生物标志物和治疗靶点。本文综述了其在各种恶性肿瘤中的表达、功能和分子机制。